
Advances in the transplant of cells into the spleen could transform one of the body’s “expendable” organs into a hub for treating diabetes, two Chinese studies have found.Research published last month by scientists at Nanjing University and other institutes found that “shielding” islet cells could improve their survival after being transplanted into the spleen to treat type 1 diabetes.They also found that the spleen – a more promising long-term survival site than the conventionally used liver...